Breaking News

Home / 2025 at 11:01AM / February 16 / At Rs 58 crore, cancer drug emerges top seller among new launches in 2024

At Rs 58 crore, cancer drug emerges top seller among new launches in 2024

February 17, 2025 ,
Enhertu, an oncology drug by AstraZeneca, led new drug sales in 2024 with Rs 58 crore, reflecting rising cancer cases. Over 3,100 new brands collectively earned Rs 1,097 crore, with significant launches in cardiac, anti-diabetic, and vitamins sectors, highlighting prevailing health patterns in India. https://ift.tt/spJaKqL

No comments

PLEASE DO NOT ENTER ANY SPAM LINK IN THE COMMENT BOX

Subscribe to: Post Comments ( Atom )